GSK's thirst for adjuvants grows

GSK's thirst for adjuvants grows

By Gregory Roumeliotis

GlaxoSmithKline (GSK) has asked vaccine developing firm Antigenics
to supply it with more of its QS-21 adjuvant as its vaccines
progress in the pipeline, while at the same the British drug giant
is pushing ahead with its own adjuvant,...

Malarial drug target revealed

Malarial drug target revealed

A potential new drug target for malaria was revealed this week
after scientists discovered the structure and function of the
malaria parasite, Plasmodium falciparum, for the first time. The
findings represent a breakthrough for future...


Follow us


View more


Featured Suppliers